0
Clinical Investigations: BRONCHIECTASIS |

Distribution of α1-Antitrypsin Alleles in Patients With Bronchiectasis*

Antoine Cuvelier, MD; Jean-Francois Muir, MD, FCCP; Marie-France Hellot, ScD; Daniel Benhamou, MD; Jean-Pierre Martin, MD, PhD; Jacques Bénichou, MD, PhD; Richard Sesboüé, MD
Author and Funding Information

*From the Respiratory and Intensive Care Department (Drs. Cuvelier, Muir, and Benhamou), Unité INSERM 295 (Drs. Cuvelier, Martin, and Sesboüé), and the Department of Biostatistics (Drs. Hellot and Bénichou), University Hospital, Rouen, France.

Correspondence to: Antoine Cuvelier, MD, Respiratory and Intensive Care Department, Hôpital de Bois-Guillaume, CHU de Rouen, 76031 Rouen CEDEX, France; e-mail:antoine.cuvelier@chu-rouen.fr



Chest. 2000;117(2):415-419. doi:10.1378/chest.117.2.415
Text Size: A A A
Published online

Study objectives: Bronchiectasis has been reported in a few patients with homozygous α1-antitrypsin (AAT) deficiency, but the distribution of AAT alleles among bronchiectatic patients is not known.

Patients and design: Two hundred two patients, 104 men and 98 women, with a mean age (SD) of 63.7 ± 15.4 years, had bronchiectasis diagnosed by CT scan alone (n = 178), bronchography with or without CT scan (n = 17), or radiography alone (n = 7). AAT phenotypes (classified according to the protease inhibitor [PI] system) were determined by isoelectric focusing in blood samples obtained from all patients. Bronchiectasis was primary in 121 cases and secondary in 81 patients. Allele and phenotype frequencies were compared retrospectively between bronchiectatic patients and healthy blood donors living in the same geographic area.

Results: The PI phenotype frequencies among patients were the following: MM, 81.18%; MS, 11.88%; MZ, 3.46%; IZ, 0.49%; IM, 0.49%; SS, 1.48%; SZ, 0.49%; and ZZ, 0.49%. The allelic frequencies among patients were the following: M, 89.1%; S, 7.67%; Z, 2.72%; and I, 0.49%. There was no difference in the distribution of alleles or phenotypes either between patients and control subjects or between patients with secondary and primary bronchiectasis. A significant difference was found between bronchiectatic patients with and without coexisting emphysema (p = 0.028). This difference was caused by an overrepresentation of PI*Z alleles in bronchiectatic patients with coexisting emphysema.

Conclusions: Our results do not support a physiopathologic implication of the AAT genes in the development of bronchiectasis. We suggest that bronchiectasis may be a consequence of emphysema in PI*Z patients rather than a primary effect.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Identification of a novel alpha1-antitrypsin variant. Respir Med Case Rep 2017;20():64-67.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543